fda warning letters glp-1 september 2025 Targets and Peptide Compounding, Advertising and 'Research Use Only' Labeling FDA sends warning letter after

For patients on daily GLP-1 formulations , the medication should be paused on the day of an elective surgery

If confirmed by subsequent larger, multicenter, randomized, and controlled studies, GLP-1 agonists may represent a novel class of drugs for migraine prevention, he continued

As a result, brands in categories from health supplements to skin care are thinking through what this change in behavior could mean for their companies

Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children

ELISA for FcRn binding analysis 96-well EIA/RIA Clear Flat Bottom Polystyrene Microplates (Corning) were coated overnight at 4 C with 8 g/mL (100 L/well) of a recombinant Fc-engineered human IgG1 mutant (YTE/KF) 98 , with specificity for 4-hydroxy-3-iodo-5-nitrophenylactic acid, diluted in DPBS (pH 7.4) (Sigma-Aldrich)